Tan Yang

1.8k total citations
37 papers, 1.5k citations indexed

About

Tan Yang is a scholar working on Biomedical Engineering, Biomaterials and Cancer Research. According to data from OpenAlex, Tan Yang has authored 37 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Biomedical Engineering, 11 papers in Biomaterials and 8 papers in Cancer Research. Recurrent topics in Tan Yang's work include Nanoplatforms for cancer theranostics (16 papers), Nanoparticle-Based Drug Delivery (11 papers) and Cancer, Hypoxia, and Metabolism (7 papers). Tan Yang is often cited by papers focused on Nanoplatforms for cancer theranostics (16 papers), Nanoparticle-Based Drug Delivery (11 papers) and Cancer, Hypoxia, and Metabolism (7 papers). Tan Yang collaborates with scholars based in China, United States and Pakistan. Tan Yang's co-authors include Guangya Xiang, Chuanchuan He, Xiang Ma, Ruicong Yan, Xiaojuan Zhang, Yao Lu, Richard M. Hoffman, Pengxuan Zhao, Ting Fan and Yan Chen and has published in prestigious journals such as Biomaterials, Journal of Agricultural and Food Chemistry and Chemical Engineering Journal.

In The Last Decade

Tan Yang

34 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tan Yang China 23 590 542 466 291 228 37 1.5k
Xiao Xu China 21 475 0.8× 615 1.1× 306 0.7× 52 0.2× 123 0.5× 56 1.3k
Shaofeng Duan China 27 488 0.8× 792 1.5× 338 0.7× 39 0.1× 263 1.2× 84 1.9k
Jianping Zhou China 29 674 1.1× 907 1.7× 801 1.7× 38 0.1× 186 0.8× 62 2.2k
Benedict Law United States 20 359 0.6× 720 1.3× 395 0.8× 29 0.1× 197 0.9× 41 1.4k
Chaofeng Mu China 24 602 1.0× 929 1.7× 684 1.5× 34 0.1× 198 0.9× 53 2.0k
Kaisheng Liu China 25 184 0.3× 827 1.5× 117 0.3× 133 0.5× 110 0.5× 62 2.1k
Fengming You China 24 452 0.8× 589 1.1× 216 0.5× 43 0.1× 120 0.5× 94 1.4k
Qiming Kan China 26 1.4k 2.3× 929 1.7× 1.1k 2.3× 59 0.2× 357 1.6× 41 2.3k
Sohee Son South Korea 18 301 0.5× 743 1.4× 369 0.8× 43 0.1× 111 0.5× 44 1.4k

Countries citing papers authored by Tan Yang

Since Specialization
Citations

This map shows the geographic impact of Tan Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tan Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tan Yang more than expected).

Fields of papers citing papers by Tan Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tan Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tan Yang. The network helps show where Tan Yang may publish in the future.

Co-authorship network of co-authors of Tan Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Tan Yang. A scholar is included among the top collaborators of Tan Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tan Yang. Tan Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Xie, Yang, Xiang D. Tang, Tan Yang, et al.. (2025). PNMA4 enhances anti-RNA virus immunity by promoting RIG-I signaling pathway. International Immunopharmacology. 165. 115446–115446.
3.
He, Xuelian, Meijing Li, Yuying Li, et al.. (2024). Copper peroxide and cisplatin co-loaded silica nanoparticles-based trinity strategy for cooperative cuproptosis/chemo/chemodynamic cancer therapy. Chemical Engineering Journal. 481. 148522–148522. 29 indexed citations
4.
Li, Miao, Xueying Sun, Tan Yang, et al.. (2024). A proton-catalyzing prodrug for PDT and glycolysis inhibition-synergistic therapy of tumor in spatiotemporal dimensions. Science China Chemistry. 67(9). 3162–3178. 4 indexed citations
5.
Liu, Shunying, Yanhai Feng, Tan Yang, et al.. (2024). Photosensitizer‐loaded hydrogels: A new antibacterial dressing. Wound Repair and Regeneration. 32(3). 301–313. 8 indexed citations
6.
Huang, Tongyi, Wenxin Wu, Tan Yang, et al.. (2023). Perfluorocarbon nanodrug induced oxygen self-enriching sonodynamic therapy improves cancer immunotherapy after insufficient radiofrequency ablation. Frontiers in Immunology. 14. 1124152–1124152. 6 indexed citations
7.
Yang, Tan, Cong Zheng, Weiqi Zeng, et al.. (2023). Activation of mGlu2/3 receptors in the striatum alleviates L-DOPA-induced dyskinesia and inhibits abnormal postsynaptic molecular expression. Pharmacology Biochemistry and Behavior. 231. 173637–173637.
8.
Huang, Jinsheng, Tan Yang, Wenxin Wu, et al.. (2022). Nanodrug shows spatiotemporally controlled release of anti-PD-L1 antibody and STING agonist to effectively inhibit tumor progression after radiofrequency ablation. Nano Today. 43. 101425–101425. 25 indexed citations
9.
Xu, Yue, et al.. (2021). Photodynamic Therapy with Tumor Cell Discrimination through RNA-Targeting Ability of Photosensitizer. Molecules. 26(19). 5990–5990. 6 indexed citations
10.
Zhang, Xiaojuan, Chuanchuan He, Yun Sun, et al.. (2021). A smart O2-generating nanocarrier optimizes drug transportation comprehensively for chemotherapy improving. Acta Pharmaceutica Sinica B. 11(11). 3608–3621. 26 indexed citations
11.
Zhang, Xiaojuan, Chuanchuan He, Yan Chen, et al.. (2021). Cyclic reactions-mediated self-supply of H2O2 and O2 for cooperative chemodynamic/starvation cancer therapy. Biomaterials. 275. 120987–120987. 98 indexed citations
13.
Zhang, Nan, Tan Yang, Liwei Yan, et al.. (2020). <p>Modulation of Tumor Hypoxia by pH-Responsive Liposomes to Inhibit Mitochondrial Respiration for Enhancing Sonodynamic Therapy</p>. International Journal of Nanomedicine. Volume 15. 5687–5700. 27 indexed citations
14.
Zhang, Xiaojuan, Chuanchuan He, Xiaoguang Liu, et al.. (2020). One-pot synthesis of a microporous organosilica-coated cisplatin nanoplatform for HIF-1-targeted combination cancer therapy. Theranostics. 10(7). 2918–2929. 36 indexed citations
15.
Chen, Yan, Chen Chen, Xiaojuan Zhang, et al.. (2019). Platinum complexes of curcumin delivered by dual-responsive polymeric nanoparticles improve chemotherapeutic efficacy based on the enhanced anti-metastasis activity and reduce side effects. Acta Pharmaceutica Sinica B. 10(6). 1106–1121. 81 indexed citations
16.
Yang, Tan, Ming Xu, Jie Liu, et al.. (2019). Ultrasound-Triggered Nanodroplets for Targeted Co-Delivery of Sorafenib/Doxorubicin for Hepatocellular Carcinoma Therapy. Journal of Biomedical Nanotechnology. 15(9). 1881–1896. 9 indexed citations
17.
Zhao, Pengxuan, Minsi Li, Yan Chen, et al.. (2019). Selenium-doped calcium carbonate nanoparticles loaded with cisplatin enhance efficiency and reduce side effects. International Journal of Pharmaceutics. 570. 118638–118638. 19 indexed citations
18.
Chen, Yan, Yao Cheng, Pengxuan Zhao, et al.. (2018). Co-delivery of doxorubicin and imatinib by pH sensitive cleavable PEGylated nanoliposomes with folate-mediated targeting to overcome multidrug resistance. International Journal of Pharmaceutics. 542(1-2). 266–279. 53 indexed citations
19.
Cheng, Yao, Pengxuan Zhao, Tan Yang, et al.. (2018). Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma. International Journal of Pharmaceutics. 545(1-2). 261–273. 133 indexed citations
20.
Yang, Tan, Bin Li, Shibo Qi, et al.. (2014). Co-delivery of Doxorubicin and Bmi1 siRNA by Folate Receptor Targeted Liposomes Exhibits Enhanced Anti-Tumor Effects in vitro and in vivo. Theranostics. 4(11). 1096–1111. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026